Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates (Q45352399)
Jump to navigation
Jump to search
scientific article published in March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates |
scientific article published in March 2013 |
Statements
1 reference
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates (English)
1 reference
Edward J Gane
1 reference
Scott Patterson
1 reference
Simone I Strasser
1 reference
Geoffrey W McCaughan
1 reference
Peter W Angus
1 reference
1 March 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference